[Dexrazoxane and cardiotoxicity in repeatedly treated patients].
Trnĕný
M
M
D000208:Acute Disease; D018943:Anthracyclines / Q000009:adverse effects*; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D006321:Heart / Q000187:drug effects*; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D016393:Lymphoma, B-Cell / Q000188:drug therapy*; D011929:Razoxane / Q000627:therapeutic use*; D012008:Recurrence
D018943:Anthracyclines; D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D002316:Cardiotonic Agents; D011929:Razoxane